Literature DB >> 16030140

Functional interactions with Pit-1 reorganize co-repressor complexes in the living cell nucleus.

Ty C Voss1, Ignacio A Demarco, Cynthia F Booker, Richard N Day.   

Abstract

The co-repressor proteins SMRT and NCoR concentrate in specific subnuclear compartments and function with DNA-binding factors to inhibit transcription. To provide detailed mechanistic understanding of these activities, this study tested the hypothesis that functional interactions with transcription factors, such as the pituitary-gland-specific Pit-1 homeodomain protein, direct the subnuclear organization and activity of co-repressor complexes. Both SMRT and NCoR repressed Pit-1-dependent transcription, and NCoR was co-immunoprecipitated with Pit-1. Immunofluorescence experiments confirmed that endogenous NCoR is concentrated in small focal bodies and that incremental increases in fluorescent-protein-tagged NCoR expression lead to progressive increases in the size of these structures. In pituitary cells, the endogenous NCoR localized with endogenous Pit-1 and the co-expression of a fluorescent-protein-labeled Pit-1 redistributed both NCoR and SMRT into diffuse nucleoplasmic compartments that also contained histone deacetylase and chromatin. Automated image-analysis methods were applied to cell populations to characterize the reorganization of co-repressor proteins by Pit-1 and mutation analysis showed that Pit-1 DNA-binding activity was necessary for the reorganization of co-repressor proteins. These data support the hypothesis that spherical foci serve as co-repressor storage compartments, whereas Pit-1/co-repressor complexes interact with target genes in more widely dispersed subnuclear domains. The redistribution of co-repressor complexes by Pit-1 might represent an important mechanism by which transcription factors direct changes in cell-specific gene expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16030140      PMCID: PMC2910337          DOI: 10.1242/jcs.02450

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  74 in total

Review 1.  Imaging into the future: visualizing gene expression and protein interactions with fluorescent proteins.

Authors:  Peter van Roessel; Andrea H Brand
Journal:  Nat Cell Biol       Date:  2002-01       Impact factor: 28.824

2.  The tamoxifen-responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes.

Authors:  Y Yamamoto; O Wada; M Suzawa; Y Yogiashi; T Yano; S Kato; J Yanagisawa
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

Review 3.  A unified theory of gene expression.

Authors:  George Orphanides; Danny Reinberg
Journal:  Cell       Date:  2002-02-22       Impact factor: 41.582

Review 4.  Targeting genes and transcription factors to segregated nuclear compartments.

Authors:  Yoh Isogai; Robert Tjian
Journal:  Curr Opin Cell Biol       Date:  2003-06       Impact factor: 8.382

Review 5.  Nuclear speckles: a model for nuclear organelles.

Authors:  Angus I Lamond; David L Spector
Journal:  Nat Rev Mol Cell Biol       Date:  2003-08       Impact factor: 94.444

6.  Distinct nuclear body components, PML and SMRT, regulate the trans-acting function of HTLV-1 Tax oncoprotein.

Authors:  Yasuo Ariumi; Takeshi Ego; Atsushi Kaida; Mikiko Matsumoto; Pier Paolo Pandolfi; Kunitada Shimotohno
Journal:  Oncogene       Date:  2003-03-20       Impact factor: 9.867

7.  Regulation of subnuclear localization is associated with a mechanism for nuclear receptor corepression by RIP140.

Authors:  Hiroshi Tazawa; Waffa Osman; Yutaka Shoji; Eckardt Treuter; Jan-Ake Gustafsson; Johanna Zilliacus
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

8.  A PIT-1 homeodomain mutant blocks the intranuclear recruitment of the CCAAT/enhancer binding protein alpha required for prolactin gene transcription.

Authors:  John F Enwright; Margaret A Kawecki-Crook; Ty C Voss; Fred Schaufele; Richard N Day
Journal:  Mol Endocrinol       Date:  2003-02

9.  Dynamic inhibition of nuclear receptor activation by corepressor binding.

Authors:  Young-Chang Sohn; Seung-Whan Kim; Seunghee Lee; Young-Yun Kong; Doe Sun Na; Soo-Kyung Lee; Jae Woon Lee
Journal:  Mol Endocrinol       Date:  2002-12-18

Review 10.  Biological roles and mechanistic actions of co-repressor complexes.

Authors:  Kristen Jepsen; Michael G Rosenfeld
Journal:  J Cell Sci       Date:  2002-02-15       Impact factor: 5.285

View more
  6 in total

1.  EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.

Authors:  Daniel Portal; Bo Zhao; Michael A Calderwood; Thomas Sommermann; Eric Johannsen; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  Retinoic Acid Induces Ubiquitination-Resistant RIP140/LSD1 Complex to Fine-Tune Pax6 Gene in Neuronal Differentiation.

Authors:  Cheng-Ying Wu; Shawna D Persaud; Li-Na Wei
Journal:  Stem Cells       Date:  2015-10-09       Impact factor: 6.277

3.  Nuclear compartmentalization of N-CoR and its interactions with steroid receptors.

Authors:  Yin Wu; Hisaya Kawate; Keizo Ohnaka; Hajime Nawata; Ryoichi Takayanagi
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

4.  Energy homeostasis targets chromosomal reconfiguration of the human GH1 locus.

Authors:  Hana Vakili; Yan Jin; Peter A Cattini
Journal:  J Clin Invest       Date:  2014-10-08       Impact factor: 14.808

5.  Dynamic interactions between Pit-1 and C/EBPalpha in the pituitary cell nucleus.

Authors:  Ignacio A Demarco; Ty C Voss; Cynthia F Booker; Richard N Day
Journal:  Mol Cell Biol       Date:  2006-08-14       Impact factor: 4.272

6.  Mapping the Dynamics of the Glucocorticoid Receptor within the Nuclear Landscape.

Authors:  Martin Stortz; Diego M Presman; Luciana Bruno; Paolo Annibale; Maria V Dansey; Gerardo Burton; Enrico Gratton; Adali Pecci; Valeria Levi
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.